but there are so many moving parts p/e analysis is more art than science. these aren't fixed income securities. find the cure to cancer or heart attacks and a much higher p/e is justified.
Ann: Half Year Results Analyst Presentation, page-101
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$296.58 |
Change
-0.110(0.04%) |
Mkt cap ! $143.6B | |||
| Open | High | Low | Value | Volume |
| $296.70 | $297.28 | $295.09 | $59.95M | 202.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 145 | $296.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $296.58 | 252 | 11 |
View Market Depth
| Last trade - 15.38pm 17/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |